Cardiff updating mCRC trial complete, preparing for Phase 3
Cardiff's first-line RAS-mutated mCRC trial achieved median PFS not reached and prepared for a registrational Phase 3 starting Q1 2027.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed